Healthcare (Prescription Drugs)

in committee · Indiana · House Jan 12, 2026

HB 1328: Charges for hospital administered drugs.

Prohibits a hospital from billing for an administered drug an amount that exceeds the lesser of the following: (1) 120% of the Medicare reimbursement rate for the administered drug. (2) The amount the hospital bills for the administered drug on June 30, 2026. Creates an exception. Requires a hospital to update the Medicare reimbursement rate for an administered drug on January 1 and July 1 of each year.

Topics ✓ HealthcareSupports HealthcareCaps hospital drug billing at 120% Medicare rate, reducing patient costs and improving affordability - directly supports healthcare access and cost control.92% confidence

Sub-Topics Hospitals Medicare Prescription Drugs

Track

in committee · Indiana · Senate Jan 8, 2026

SB 221: Pharmacist treatment by standing order.

Requires the state health commissioner to issue a standing order, prescription, or protocol to allow a pharmacist to test, treat, or prescribe, if specified requirements are met. Provides a pharmacist with civil immunity in the testing, treating, or prescribing unless the pharmacist's actions constitute gross negligence, willful or wanton misconduct, or intentional wrongdoing. Requires the Indiana board of pharmacy to adopt rules concerning a pharmacist testing, treating, or prescribing for individuals.

Topics ✓ HealthcareSupports HealthcareExpands pharmacist authority for testing/treatment, improving patient access to healthcare services without requiring physician oversight.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · Indiana · Senate Jan 5, 2026

SB 150: Insulin price cap.

Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of prescription insulin drugs at an amount not to exceed $35, regardless of the number of prescriptions and different types of insulin prescribed and filled during that period.

Topics ✓ HealthcareSupports HealthcareCaps insulin costs at $35/month, reducing patient financial burden and improving access to essential medication per bill summary.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · Indiana · House Jan 8, 2026

HB 1405: Prescription drug assistance program for the elderly.

Establishes the prescription drug assistance program for the elderly (program) to be administered by the division of aging. Sets forth requirements of the program. Establishes the prescription drug assistance program for the elderly fund. Creates a Class A misdemeanor for fraud under the program.

Topics ✓ HealthcareSupports HealthcareEstablishes prescription drug assistance program for elderly, expanding medication access and funding via dedicated fund, directly supporting healthcare access for seniors.90% confidence

Sub-Topics Prescription Drugs Tags Seniors

Track

passed · Indiana · Senate Jan 28, 2026

SB 157: Disclosures related to prescription drugs.

Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.

Topics ✓ HealthcareSupports HealthcareMandates cost transparency for generic drugs, potentially improving patient access to affordable medications by informing purchasing decisions.75% confidence

Sub-Topics Prescription Drugs

Track

signed · Indiana · House Mar 3, 2026

HB 1114: Coverage for certain cancer prescriptions.

Prohibits a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization that provides coverage for advanced, metastatic cancer and associated conditions from requiring that, before providing coverage for a prescription drug, the insured fail to successfully respond to a different prescription drug or prove a history of failure of a different prescription drug.

Topics ✓ HealthcareSupports HealthcareProhibits insurers from requiring prior drug failure for advanced cancer coverage, directly improving patient access to necessary treatments without unnecessary barriers.95% confidence ✓ Labor & EmploymentSupports Labor & EmploymentEnsures state employees' access to cancer treatment without prior drug failure requirements, strengthening health benefits tied to employment.90% confidence

Sub-Topics Insurance Prescription Drugs Public Employees